London’s Closed Loop names Kate Woolland CEO
Plus: Updates from Upstream Bio, Veraxa and Bora
Closed Loop Medicine Ltd. promoted Kate Woolland to CEO from COO. She is tasked with guiding the London-based precision dosing company’s software-as-a-medical-device (SaMD) platform from its product development phase into the next phase: identifying partners, enabling partner-led deployment and scaling the platform. She succeeds founding CEO Hakim Yadi.
Stacy Price is joining inflammatory disease company Upstream Bio Inc. (NASDAQ:UPB) as chief technology officer, with responsibility for CMC and drug delivery as the company advances anti-TSLPR antibody verekitug. She was chief technology and manufacturing officer at Invivyd Inc. (NASDAQ:IVVD), and before that served as chief technical officer at Akouos Inc. before that company’s acquisition by Eli Lilly and Co. (NYSE:LLY)...